Lars Erik Holmqvist

Age : 62

Public asset : 2,439,160 USD

Linked companies :

H. Lundbeck A/S -

ALK-Abelló A/S -

Tecan Group AG -

Vitrolife AB (publ) -

Biovica International AB (publ)

Summary

Currently, Lars Erik Holmqvist holds the position of Chairman for Biovica International AB and Chairman at Fastihets AB Skutviken.

He is also on the board of 6 other companies.

He previously was SVP, President-Diagnostics & Genomics Group at Agilent Technologies, Inc. President & Chief Executive Officer at Cytologix Corp. and President & Chief Executive Officer at Dako Denmark ApS (both are subsidiaries of Agilent Technologies, Inc.), Vice President for Pharmacia Upjohn, Executive Member at Applera Corp., Vice President-Vascular & Cardiac Surgery at Medtronic Europe SARL and Vice President of Applied Biosystems Ltd.

Lars Erik Holmqvist received an undergraduate degree from Stockholm School of Economics and an MBA from INSEAD.

Current positions of Lars Erik Holmqvist

Name	Title	Since
H. Lundbeck A/S (Pharmaceuticals)	Independent Director	2015
ALK-Abelló A/S (Pharmaceuticals)	Director	2015
Tecan Group AG (Office Equipment)	Non-Executive Director	2015
Vitrolife AB (publ) (Medical Equipment, Supplies & Distribution)	Independent Director	2018
Biovica International AB (publ) (Biotechnology & Medical Research)	Chairman	2019
Fastihets AB Skutviken	Chairman	-
Lundbeck Foundation	Trustee	2015
Naga UK Topco Ltd.	Director	-

Holdings of Lars Erik Holmqvist

Name	Equities	%	Valuation
Biovica International AB (publ) (BIOVIC B) (Biotechnology & Medical Research)	534,536	2.44%	2,070,691 USD
H. Lundbeck A/S	15,000	0.0075%	368,469 USD

Lars Erik Holmqvist: Personal Network

Name	Linked companies
Lene Skole-Sørensen	H. Lundbeck A/S ALK-Abelló A/S Lundbeck Foundation
Ludovic Tranholm Otterbein	H. Lundbeck A/S Lundbeck Foundation
Henrik Sindal Jensen	H. Lundbeck A/S Lundbeck Foundation
Santiago Arroyo	H. Lundbeck A/S
Johan Luthman	H. Lundbeck A/S
Keld Flintholm Jørgensen	H. Lundbeck A/S
Kristoffer Forsmark	Vitrolife AB (publ)
Lars Bang	H. Lundbeck A/S
Patrik Tolf	Vitrolife AB (publ)
Vesa Veikko Koskinen	Vitrolife AB (publ)